Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.

Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H.

Nat Med. 2007 Oct;13(10):1241-7.

PMID:
17906637
2.

Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?

Purohit V, Rapaka RS, Rutter J, Shurtleff D.

J Neuroimmune Pharmacol. 2012 Sep;7(3):519-23. doi: 10.1007/s11481-012-9356-1. Review.

PMID:
22527633
3.
4.

Reservoirs of HIV replication after successful combined antiretroviral treatment.

Belmonte L, Baré P, de Bracco MM, Ruibal-Ares BH.

Curr Med Chem. 2003 Feb;10(4):303-12. Review.

PMID:
12570703
5.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.

Redel L, Le Douce V, Cherrier T, Marban C, Janossy A, Aunis D, Van Lint C, Rohr O, Schwartz C.

J Leukoc Biol. 2010 Apr;87(4):575-88. doi: 10.1189/jlb.0409264. Review.

PMID:
19801499
6.

Reversal of HIV-1 latency with anti-microRNA inhibitors.

Zhang H.

Int J Biochem Cell Biol. 2009 Mar;41(3):451-4. doi: 10.1016/j.biocel.2008.07.016. Review.

7.

[Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].

Llibre JM, Martínez-Picado J.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:17-22. Review. Spanish.

PMID:
19572421
8.

Mechanisms of HIV latency: an emerging picture of complexity.

Margolis DM.

Curr HIV/AIDS Rep. 2010 Feb;7(1):37-43. doi: 10.1007/s11904-009-0033-9. Review.

PMID:
20425056
9.

The role of microRNAs in HIV-1 pathogenesis and therapy.

Swaminathan S, Murray DD, Kelleher AD.

AIDS. 2012 Jul 17;26(11):1325-34. doi: 10.1097/QAD.0b013e328352adca. Review.

PMID:
22382145
10.

The challenge of viral reservoirs in HIV-1 infection.

Blankson JN, Persaud D, Siliciano RF.

Annu Rev Med. 2002;53:557-93. Review.

PMID:
11818490
11.

Latency: the hidden HIV-1 challenge.

Marcello A.

Retrovirology. 2006 Jan 16;3:7. Review.

12.

HIV type-1 latency: targeted induction of proviral reservoirs.

Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z.

Antivir Chem Chemother. 2009;19(5):177-87. Review.

PMID:
19483266
13.

The challenge of finding a cure for HIV infection.

Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ.

Science. 2009 Mar 6;323(5919):1304-7. doi: 10.1126/science.1165706. Review.

PMID:
19265012
14.

MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes.

Chiang K, Rice AP.

Viruses. 2012 Sep;4(9):1390-409. doi: 10.3390/v4091390. Review.

15.

Human immunodeficiency virus interactions with CD8+ T lymphocytes.

Saksena NK, Wu JQ, Potter SJ, Wilkinson J, Wang B.

Curr HIV Res. 2008 Jan;6(1):1-9. Review.

PMID:
18288969
16.

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J.

Nat Rev Microbiol. 2009 Nov;7(11):798-812. doi: 10.1038/nrmicro2223. Review.

PMID:
19834480
17.

How to engage Cofilin.

Bukrinsky M.

Retrovirology. 2008 Sep 22;5:85. doi: 10.1186/1742-4690-5-85. Review.

18.

Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.

Pan X, Baldauf HM, Keppler OT, Fackler OT.

Cell Res. 2013 Jul;23(7):876-85. doi: 10.1038/cr.2013.74. Review.

19.

Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.

Pomerantz RJ.

Arch Immunol Ther Exp (Warsz). 2004 Sep-Oct;52(5):297-306. Review.

PMID:
15507870
20.

HIV-1 latency in monocytes/macrophages.

Kumar A, Abbas W, Herbein G.

Viruses. 2014 Apr 22;6(4):1837-60. doi: 10.3390/v6041837. Review.

Items per page

Supplemental Content

Support Center